PDCD1 and non-small cell lung carcinoma: Furthermore, programmed death-ligand 1 (PD-L1)/programmed cell death protein 1 (PD-1) expression has been shown to be aberrant in anywhere from 19% to 100% of NSCLC patients [7-11].